Spectrum of gastroparesis in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 2, 2012, Pages 166-172

  Waseem, Shamaila ^a   Islam, Saleem ^b   Kahn, Genie ^b   Moshiree, Baharak ^b   Talley, Nicholas J ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

etiologies; gastroparesis; identify; prevalence; retrospective; scintigraphy

Indexed keywords

AZITHROMYCIN; CISAPRIDE; ERYTHROMYCIN; TEGASEROD;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BLOATING; CHILD; DIABETES MELLITUS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUTRITIONAL SUPPORT; PRESCHOOL CHILD; PRIORITY JOURNAL; SATIETY; SCHOOL CHILD; STOMACH EMPTYING; STOMACH PARESIS; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ABDOMINAL PAIN; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DRUG TOXICITY; ERYTHROMYCIN; FEMALE; FOLLOW-UP STUDIES; GASTRIC EMPTYING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; GASTROPARESIS; HUMANS; INFANT; MALE; NAUSEA; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; VOMITING; WEIGHT LOSS; YOUNG ADULT;

EID: 84863851598     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31824cf06e     Document Type: Article

References (29)

1. Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006;18: 263-83.
2. Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci 2002;47:2664-8.
3. Franzese A, Borrelli O, Corrado G, et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 2002;16:951-7.
4. Dahshan A, Poulick J, Tolia V. Special feature: pathological case of the month. Pernicious anemia and gastric atrophy in an adolescent female with multiorgan problems. Arch Pediatr Adolesc Med 2001;155:609-10.
5. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998;43:2398-404.
6. Boccia G, Buonavolontà R, Coccorullo P, et al. Dyspeptic symptoms in children: the result of a constipation-induced cologastric brake? Clin Gastroenterol Hepatol 2008;6:556-60.
7. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 2000;45:809-18.
8. Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009;136:1225-33.
9. Hyams JS, Davis P, Sylvester FA, et al. Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr 2000; 30:413-8.
10. Chitkara DK, Camilleri M, Zinsmeister AR, et al. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr 2005;146:500-5.
11. Chitkara DK, Delgado-Aros S, Bredenoord AJ, et al. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr 2003;143:609-13.
12. Ali T, Hasan M, Hamadani M, et al. Gastroparesis. South Med J 2007;100:281-6.
13. DiBaise JK, Quigley EM. Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience. J Clin Gastroenterol 1999;28:131-4.
14. Moshiree B, McDonald R, Hou W, et al. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2010;55:675-83.
15. Franzese A, Borrelli O, Corrado G, et al. Domperidone is more effective than cisapride in children with diabetic gastroparesis. Aliment Pharmacol Ther 2002;16:951-7.
16. Matsui K, Yamashita S, Shibasaki J, et al. Bethanechol for neonatal transient gastrointestinal dismotility in two cases of congenital myotonic dystrophy. No To Hattatsu 2007;39:304-8.
17. Donohoe KJ, Maurer AH, Ziessman HA, et al. Society of Nuclear Medicine Procedure Guideline for Gastric Emptying and Motility, 2005. http://interactive.snm.org/docs/pg-ch08-0403.pdf. Accessed September 28, 2005.
18. Larson JM, Tavakkoli A, Drane WE, et al. Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis. J NeurogastroenterolMotil 2010;16:407-13.
19. Klauser AG, Voderholzer WA, Knesewitsch PA, et al. What is behind dyspepsia? Dig Dis Sci 1993;38:147-54.
20. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004;13:833-44.
21. Talley NJ, Locke GR 3rd, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006;55:933-9.
22. Buckles DC, Sarosiek I, McMillin C, et al. Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. Am J Med Sci 2004;327:1-4.
23. Parkman HP, Camilleri M, Farrugia G, et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2010;22:113-33.
24. Petrakis IE, Vrachassotakis N, Sciacca V, et al. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 1999; 34:396-403.
25. Bielefeldt K, Raza N, Zickmund SL. Different faces of gastroparesis. World J Gastroenterol 2009;15:6052-60.
26. McCallum RW, Berkowitz DM, Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 1981;80:285-91.
27. DiBaise JK, Quigley EM. Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience. J Clin Gastroenterol 1999;28:131-4.
28. McCallum RW, Valenzuela G, Polepalle S, et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther 1991;258:136-42.
29. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008;103:753-63.